当前位置:首页 - 行情中心 - 东亚药业(605177) - 财务分析 - 现金流量表

东亚药业

(605177)

  

流通市值:24.14亿  总市值:24.37亿
流通股本:1.14亿   总股本:1.15亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金176,413,185.57653,293,092.1454,908,438.63280,416,803.57
  收到的税费返还5,535,894.656,074,573.6353,106,520.2719,647,676.04
  收到其他与经营活动有关的现金4,550,388.5341,907,041.5415,504,734.446,760,507.85
  经营活动现金流入小计186,499,468.7751,274,707.27523,519,693.34306,824,987.46
  购买商品、接受劳务支付的现金54,331,715.82723,297,732.96563,822,707.12396,825,140.87
  支付给职工以及为职工支付的现金57,659,661.14201,028,541.02154,073,914.85109,225,340.84
  支付的各项税费31,723,796.8232,700,571.6419,130,805.9714,889,747.5
  支付其他与经营活动有关的现金10,650,356.7463,103,857.6139,218,350.8223,223,162.29
  经营活动现金流出小计154,365,530.521,020,130,703.23776,245,778.76544,163,391.5
  经营活动产生的现金流量净额32,133,938.18-268,855,995.96-252,726,085.42-237,338,404.04
二、投资活动产生的现金流量:
  收回投资收到的现金130,000,000861,082,507.23385,700,000227,700,000
  取得投资收益收到的现金524,137.153,320,236.551,970,977.31742,567.67
  处置固定资产、无形资产和其他长期资产收回的现金净额1,117,509.421,438,491.4868,612.03435,659.43
  收到的其他与投资活动有关的现金--104,802.75-
  投资活动现金流入小计131,641,646.57865,841,235.18388,644,392.09228,878,227.1
  购建固定资产、无形资产和其他长期资产支付的现金6,983,543.9674,256,035.0464,041,760.8745,806,812.8
  投资支付的现金73,000,000927,900,000502,900,000372,450,000
  投资活动现金流出小计79,983,543.961,002,156,035.04566,941,760.87418,256,812.8
  投资活动产生的现金流量净额51,658,102.61-136,314,799.86-178,297,368.78-189,378,585.7
三、筹资活动产生的现金流量:
  取得借款收到的现金19,800,000358,980,000317,280,000284,280,000
  收到其他与筹资活动有关的现金-69,668,239.5944,955,739.59-
  筹资活动现金流入小计19,800,000428,648,239.59362,235,739.59284,280,000
  偿还债务支付的现金39,800,000155,780,000115,000,000115,000,000
  分配股利、利润或偿付利息支付的现金1,812,815.38,614,092.56,699,584.682,212,951.88
  支付其他与筹资活动有关的现金58,428.34104,571,864.0972,592,908.281,433,071.88
  筹资活动现金流出小计41,671,243.64268,965,956.59194,292,492.96118,646,023.76
  筹资活动产生的现金流量净额-21,871,243.64159,682,283167,943,246.63165,633,976.24
四、汇率变动对现金及现金等价物的影响-347,708.981,128,906.781,186,642.01995,806.38
五、现金及现金等价物净增加额61,573,088.17-244,359,606.04-261,893,565.56-260,087,207.12
  加:期初现金及现金等价物余额243,966,360.23488,325,966.27488,325,966.27488,325,966.27
  期末现金及现金等价物余额305,539,448.4243,966,360.23226,432,400.71228,238,759.15
补充资料:
  净利润--82,432,149.13--30,264,551.62
  资产减值准备-44,115,906.92-31,980,426.01
  固定资产和投资性房地产折旧-149,003,507.72-69,588,281.9
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-149,003,507.72-69,588,281.9
  无形资产摊销-2,590,094.89-1,266,211.96
  长期待摊费用摊销-4,431,084.95-2,147,591.38
  处置固定资产、无形资产和其他长期资产的损失-387,524.12-4,303.49
  固定资产报废损失-2,798,211.15-1,697,729.25
  财务费用-16,695,785.23-4,100,112.13
  投资损失--2,934,751.91--1,467,591.82
  递延所得税--18,080,952.41--10,157,712.12
  其中:递延所得税资产减少--17,916,125.36--10,306,278.1
    递延所得税负债增加--164,827.05-148,565.98
  存货的减少-133,270,572.33--70,673,691.01
  经营性应收项目的减少--174,455,845.41--76,246,777.6
  经营性应付项目的增加--361,361,504.17--161,733,955.67
  其他-13,541,572.52-500,853.27
  不涉及现金收支的投资和筹资活动金额其他项目---2,789,810.65
  现金的期末余额-243,966,360.23-228,238,759.15
  减:现金的期初余额-488,325,966.27-488,325,966.27
  现金及现金等价物的净增加额--244,359,606.04--260,087,207.12
公告日期2026-04-302026-04-232025-10-312025-08-29
审计意见(境内)标准无保留意见
TOP↑